In contrast with the results of TSPO BP in AD and PD, investigations with second-generation radiotracers, such as 18F-PBR06 and 11C-PBR28, confirmed previous findings, thereby acknowledging TSPO as a potential marker not only for diagnosing HD but also for evaluation of the effect of treatment [83,84]. Here, TSPO is linked to Huntington disease.